Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Sarkar

Showing results (11-20 of 669) with videos related to

Pageof 67
Sort By:
Cancer Treatment Reviews|December 29, 2007
Evolving role of uPA/uPAR system in human cancersKathleen Dass, Aamir Ahmad, Asfar S Azmi, et al.
Cancer Research|May 3, 2006
Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cellsKm Wahidur Rahman, Yiwei Li, Zhiwei Wang, et al.
BMC Cancer|January 26, 2006
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell lineDavid A Davis, Sarah H Sarkar, Maha Hussain, et al.
Journal of Virology|January 1, 1978
Synthesis and processing of precursor polypeptides to murine mammary tumor virus structural proteinsJ Racevskis, N H Sarkar
Cancer Investigation|November 25, 2003
Soy isoflavones and cancer preventionFazlul H Sarkar, Yiwei Li
Clinical & Experimental Metastasis|July 1, 1991
Colonization characteristics of a murine mammary tumor cell line that metastasizes frequently to the heartA Hossain, N H Sarkar
Cancer Letters|September 6, 2002
Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genisteinYiwei Li, Fazlul H Sarkar
The Journal of Nutrition|December 1, 2004
Indole-3-carbinol and prostate cancerFazlul H Sarkar, Yiwei Li
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathwayYiwei Li, Fazlul H Sarkar
Cancer Treatment Reviews|August 8, 2009
Harnessing the fruits of nature for the development of multi-targeted cancer therapeuticsFazlul H Sarkar, Yiwei Li
Pageof 67

Showing results (11-20 of 669) with videos related to

Sort By:
Pageof 67
Cancer Treatment Reviews|December 29, 2007
Evolving role of uPA/uPAR system in human cancersKathleen Dass, Aamir Ahmad, Asfar S Azmi, et al.
Cancer Research|May 3, 2006
Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cellsKm Wahidur Rahman, Yiwei Li, Zhiwei Wang, et al.
BMC Cancer|January 26, 2006
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell lineDavid A Davis, Sarah H Sarkar, Maha Hussain, et al.
Journal of Virology|January 1, 1978
Synthesis and processing of precursor polypeptides to murine mammary tumor virus structural proteinsJ Racevskis, N H Sarkar
Cancer Investigation|November 25, 2003
Soy isoflavones and cancer preventionFazlul H Sarkar, Yiwei Li
Clinical & Experimental Metastasis|July 1, 1991
Colonization characteristics of a murine mammary tumor cell line that metastasizes frequently to the heartA Hossain, N H Sarkar
Cancer Letters|September 6, 2002
Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genisteinYiwei Li, Fazlul H Sarkar
The Journal of Nutrition|December 1, 2004
Indole-3-carbinol and prostate cancerFazlul H Sarkar, Yiwei Li
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2002
Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathwayYiwei Li, Fazlul H Sarkar
Cancer Treatment Reviews|August 8, 2009
Harnessing the fruits of nature for the development of multi-targeted cancer therapeuticsFazlul H Sarkar, Yiwei Li
Pageof 67